EZH2 marks polyfunctional memory T cells and controls tumor immunity

被引：0
|
作者：
Zhao, Ende [1 ]
Maj, Tomasz [2 ]
Kryczek, Ilona [2 ]
Zhao, Lili [2 ]
Wei, Shuang [2 ]
Wan, Shanshan [2 ]
Crespo, Joel [2 ]
Szeliga, Wojciech [2 ]
Vatan, Linda [2 ]
Wu, Ke [1 ]
Chinnaiyan, Arul M. [2 ]
Welling, Theodore H. [2 ]
Marquez, Victor E. [3 ]
Kotarski, Jan [4 ]
Zhang, Yi [2 ]
Liu, Rebecca [2 ]
Tao, Kaixiong [1 ]
Wang, Guobin [1 ]
Zou, Weiping [2 ]
机构：
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan 430074, Peoples R China
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] NCI Frederick, Frederick, MD USA
[4] Med Univ Lublin, Lublin, Poland
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-4078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Histone Methyltransferase Ezh2 Controls T-Cell Immunity by Regulating Bioenergetic Metabolism
    He, Shan
    Xie, Fang
    Tong, Qing
    Mochizuki, Kazuhiro
    Liu, Yongnian
    Lapinski, Philip E.
    Mineishi, Shin
    Mani, Ram Shankar
    Marquez, Victor E.
    Chinnaiyan, Arul M.
    King, Philip D.
    Zhang, Yi
    BLOOD, 2012, 120 (21)
  • [2] Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity
    Wang, David
    Quiros, Jason
    Mahuron, Kelly
    Pai, Chien-Chun
    Ranzani, Valeria
    Young, Arabella
    Silveria, Stephanie
    Harwin, Tory
    Abnousian, Arbi
    Pagani, Massimiliano
    Rosenblum, Michael D.
    Van Gool, Frederic
    Fong, Lawrence
    Bluestone, Jeffrey A.
    DuPage, Michel
    CELL REPORTS, 2018, 23 (11): : 3262 - 3274
  • [3] The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8+ Memory T Cells for Antitumor Immunity
    He, Shan
    Liu, Yongnian
    Meng, Lijun
    Sun, Hongxing
    Wang, Ying
    Ji, Yun
    Purushe, Janaki
    Chen, Pan
    Li, Changhong
    Madzo, Jozef
    Issa, Jean-Pierre
    Soboloff, Jonathan
    Reshef, Ran
    Moore, Bethany
    Gattinoni, Luca
    Zhang, Yi
    BLOOD, 2017, 130
  • [4] Selective impairment of intratumoral regulatory T cells by targeting Ezh2 enhances cancer immunity
    Wang, David Q.
    Quiros, Jason R.
    Pai, Chien-Chun S.
    Fong, Lawrence H.
    Bluestone, Jeffrey A.
    DuPage, Michel J.
    CANCER RESEARCH, 2017, 77
  • [5] Targeting EZH2 Selectively Alters Intratumoral Regulatory T Cells to Enhance Cancer Immunity
    DuPage, Michel
    Wang, David
    Quiros, Jason
    Mahuron, Kelly
    Pai, Chien-Chun
    Ranzani, Valeria
    Young, Arabella
    Silveria, Stephanie
    Harwin, Tory
    Abnousian, Arbi
    Pagani, Massimiliano
    Rosenblum, Michael
    Van Gool, Frederic
    Fong, Lawrence
    Bluestone, Jeffrey A.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [6] The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
    Ying Wang
    Tien Bui
    Yi Zhang
    International Journal of Hematology, 2022, 116 : 837 - 845
  • [7] The pleiotropic roles of EZH2 in T-cell immunity and immunotherapy
    Wang, Ying
    Bui, Tien
    Zhang, Yi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (06) : 837 - 845
  • [8] The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
    Zingg, Daniel
    Arenas-Ramirez, Natalia
    Sahin, Dilara
    Rosalia, Rodney A.
    Antunes, Ana T.
    Haeusel, Jessica
    Sommer, Lukas
    Boyman, Onur
    CELL REPORTS, 2017, 20 (04): : 854 - 867
  • [9] Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
    Christofides, Anthos
    Karantanos, Theodoros
    Bardhan, Kankana
    Boussiotis, Vassiliki A.
    ONCOTARGET, 2016, 7 (51) : 85624 - 85640
  • [10] Ezh2 Lines Up the Chromatin in T Regulatory Cells
    Wu, Chuan
    Chen, Zuojia
    Kuchroo, Vijay K.
    IMMUNITY, 2015, 42 (02) : 201 - 203
12345